Erik Jessen
Impact in
- Genetics top 10%
- Bacterial Genetics and Biotechnology
-
- Multiple Myeloma Research and Treatments
Papers in
-
- Protein Degradation and Inhibitors 2
- Histone Deacetylase Inhibitors Research 2
-
- Multiple Myeloma Research and Treatments 5
- Acute Myeloid Leukemia Research 2
- Co-authors
- Rachel A. Mooney (1 shared paper)Robert Landick (1 shared paper)Jason M. Peters (1 shared paper)Frances Tran (1 shared paper)Jeffrey A. Grass (1 shared paper)Shaji Kumar (6 shared papers)Dragan Jevremović (4 shared papers)Taro Hitosugi (3 shared papers)
- Journals
- Cancer Research (3 papers)Blood Cancer Journal (2 papers)Science Advances (2 papers)American Journal of Clinical Pathology (2 papers)Scientific Reports (1 paper)
- Partner nations
- United StatesPuerto RicoCanada
In The Last Decade
Erik Jessen
26 papers receiving 391 citations
Peers
Comparison fields: 5 of 60
- Genetics 164
- Hematology 59
- Molecular Biology 261
- Ecology 77
- Cancer Research 33
Countries citing papers authored by Erik Jessen
This map shows the geographic impact of Erik Jessen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erik Jessen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erik Jessen more than expected).
Fields of papers citing papers by Erik Jessen
This network shows the impact of papers produced by Erik Jessen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erik Jessen. The network helps show where Erik Jessen may publish in the future.
Co-authors
The 25 scholars most cited alongside Erik Jessen, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 29 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 209 | |
| 2 | 2019 | 27 | |
| 3 | 2020 | 27 | |
| 4 | 2020 | 23 | |
| 5 | 2019 | 16 | |
| 6 | 2020 | 9 | |
| 7 | 2022 | 9 | |
| 8 | 2024 | 9 | |
| 9 | 2021 | 9 | |
| 10 | 2020 | 8 | |
| 11 | 2014 | 6 | |
| 12 | 2014 | 6 | |
| 13 | 2023 | 5 | |
| 14 | 2024 | 5 | |
| 15 | 2025 | 4 | |
| 16 | 2024 | 4 | |
| 17 | Preparation of antibodies against the fourth complement component (C4) and development of a direct electroimmunoassay for quantification of C4d. | 1985 | 4 |
| 18 | 2024 | 3 | |
| 19 | 2024 | 3 | |
| 20 | 2020 | 3 |
About Erik Jessen
Erik Jessen is a scholar working on Molecular Biology, Hematology, Oncology, Immunology and Surgery, having authored 29 papers that have together received 395 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers), Protein Degradation and Inhibitors (2 papers), Cancer Mechanisms and Therapy (2 papers), Acute Myeloid Leukemia Research (2 papers), Histone Deacetylase Inhibitors Research (2 papers) and Peptidase Inhibition and Analysis (2 papers). The work is most often cited by research in Genetics (164 citations), Hematology (59 citations), Molecular Biology (261 citations), Ecology (77 citations) and Cancer Research (33 citations). Erik Jessen has collaborated with scholars based in United States, Puerto Rico and Canada. Frequent co-authors include Rachel A. Mooney, Robert Landick, Jason M. Peters, Frances Tran, Jeffrey A. Grass, Shaji Kumar, Dragan Jevremović, Taro Hitosugi, Wilson I. Gonsalves and Surendra Dasari. Their work appears in journals such as Cancer Research, Blood Cancer Journal, Science Advances, American Journal of Clinical Pathology and Scientific Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.